Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Interventional × High-Throughput Nucleotide Sequencing × Clear all

Phase

Phase NA 2 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cisplatin 1329 Carboplatin 1245 Cyclophosphamide 1185 Bevacizumab 1085 Gemcitabine 1081 Paclitaxel 1062 Radiotherapy 1045 Docetaxel 971 pembrolizumab 904 Oxaliplatin 818 Capecitabine 801 Fluorouracil 753 Rituximab 654 Doxorubicin 594 Nivolumab 588 Dexamethasone 587 Etoposide 583 Irinotecan 562 Leucovorin 519 Pemetrexed 443 Drug Therapy 421 Cetuximab 416 Cytarabine 408 Trastuzumab 406 Magnetic Resonance Spectroscopy 395 Filgrastim 390 Prednisone 377 Lenalidomide 354 Bortezomib 353 Temozolomide 349

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04996836 2021-08-13

BR(E)2ASTOME

University of Campania Luigi Vanvitelli

Phase 2 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡